Nordicus Partners Corp financial data

Symbol
NORD on OTC
Location
280 South Beverly Dr., Suite 505, Beverly Hills, CA
State of incorporation
DE
Fiscal year end
March 31
Former names
EKIMAS Corp (to 5/3/2023), AdvanSource Biomaterials Corp (to 4/3/2020), CARDIOTECH INTERNATIONAL INC (to 9/8/2008)
Latest financial report
10-Q - Q4 2024 - Apr 2, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 28.8 % -70.2%
Debt-to-equity 1.13 % -57.1%
Return On Equity -9.33 % +95.5%
Return On Assets -9.23 % +95.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.2M shares
Common Stock, Shares, Outstanding 17.2M shares
Entity Public Float 5.59M USD +765%
Common Stock, Value, Issued 17.2K USD +56.7%
Weighted Average Number of Shares Outstanding, Basic 11.6M shares +938%
Weighted Average Number of Shares Outstanding, Diluted 11.6M shares +938%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.5K USD
Research and Development Expense 418K USD
General and Administrative Expense 258K USD +80.9%
Operating Income (Loss) -2.12M USD +23.4%
Nonoperating Income (Expense) -280K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.4M USD +13%
Net Income (Loss) Attributable to Parent -2.38M USD +13.6%
Earnings Per Share, Basic -0.11 USD/shares +79.6%
Earnings Per Share, Diluted -0.11 USD/shares +79.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.8K USD +676%
Assets, Current 77.8K USD +101%
Intangible Assets, Net (Excluding Goodwill) 423K USD
Goodwill 57.4M USD
Other Assets, Noncurrent 318K USD +11931%
Assets 59.7M USD +3222%
Contract with Customer, Liability, Current 7.5K USD
Liabilities, Current 889K USD +1312%
Liabilities 889K USD +1312%
Accumulated Other Comprehensive Income (Loss), Net of Tax -47.9K USD -534%
Retained Earnings (Accumulated Deficit) -46.2M USD -8.88%
Stockholders' Equity Attributable to Parent 58.8M USD +3292%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.78M USD +6340%
Liabilities and Equity 59.7M USD +3222%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -218K USD
Net Cash Provided by (Used in) Financing Activities 60K USD +140%
Net Cash Provided by (Used in) Investing Activities 135K USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 17.2M shares +56.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28K USD -27.8%
Deferred Tax Assets, Valuation Allowance 2.38M USD +2.69%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.42M USD +12.4%
Deferred Tax Assets, Operating Loss Carryforwards 2.38M USD +2.69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 105M USD +138%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 472K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%